ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004027:Diencephalon / Q000187:drug effects; D004149:Dioxoles / Q000008:administration & dosage / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D005453:Fluorescence; D006614:Hindlimb / Q000187:drug effects; D066298:In Vitro Techniques; D007498:Iris / Q000187:drug effects / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology*; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013687:Telencephalon / Q000187:drug effects; D014316:Tritium
D001593:Benzyl Compounds; D002395:Catecholamines; D004149:Dioxoles; D008781:Methyltyrosines; D010879:Piperazines; D011743:Pyrimidines; D011941:Receptors, Adrenergic; D014316:Tritium; D012701:Serotonin; D001058:Apomorphine; D009526:Nialamide; D004298:Dopamine